Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial
作者
Noor Wortelboer,Seamus Kent,Inge R. Konings,Annemiek van Ommen‐Nijhof,Vincent van der Noort,E. van den Pol,Cristina Guerrero Páez,Marlies L. van Bekkum,F. Van den Berkmortel,Helga Droogendijk,Danny Houtsma,Hendrika M. Oosterkamp,Annemieke van der Padt‐Pruijsten,Ester Siemerink,Jolien Tol,Annette A. van Zweeden,A. Elise van Leeuwen‐Stok,Gabe S. Sonke,Agnes Jager,Hedwig M. Blommestein
PDF的下载单位、IP信息已删除
(2025-6-4)
潇洒的惋清
最爱巧克力和抹茶
Criminology34
Yyyyyyyyy
GingerF
无极微光
七月流火
克克
wjh
morena
claudio12
Hayat
贪玩的秋柔
OsamaKareem
vin
活泼的远航
YifanWang
愔愔
Rita
Elm
皖公网安备34019202002308
